Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Terminated1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT00210392Phase 2Terminated
VELCADE in MALT Lymphoma Pretreated With More Than One Prior Systemic Therapy
Lymphoma, Mucosa-Associated Lymphoid Tissue
Studychair

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

International Extranodal Lymphoma Study Group

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Antonio Salar, MD

Hospital del Mar

Moderately Similar
1 trials

Shared therapeutic areas:

Lymphoma, B-Cell, Marginal Zone
Similarity Score30%

Emilio Montserrat, MD

Clinic Hospital Universitari, Hematology. Barcelona

Moderately Similar
1 trials

Shared therapeutic areas:

Lymphoma, B-Cell, Marginal Zone

Worked with same sponsors:

International Extranodal Lymphoma Study Group (IELSG)
Similarity Score30%

Werner Dolak, MD

Medical University of Vienna, Department of Internal Medicine III, Division of Gastroenterologie and Hepatologie

Moderately Similar
3 trials

Shared therapeutic areas:

Lymphoma, B-Cell, Marginal Zone
Similarity Score30%

Eulogio Conde, MD

Marqués de Valdecilla Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Lymphoma, B-Cell, Marginal Zone
Similarity Score30%

Giovanni Martinelli, MD

Hemato-oncology. European Oncology Institute. Milan

Moderately Similar
1 trials

Shared therapeutic areas:

Lymphoma, B-Cell, Marginal Zone

Worked with same sponsors:

International Extranodal Lymphoma Study Group (IELSG)
Similarity Score30%

José Javier Sánchez-Blanco, MD

Morales Meseguer Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Lymphoma, B-Cell, Marginal Zone
Similarity Score30%

Reyes Arranz, MD

La Princesa Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Lymphoma, B-Cell, Marginal Zone
Similarity Score30%

Maurizio Martelli, MD

Hematology. Università La Sapienza. Roma

Moderately Similar
1 trials

Shared therapeutic areas:

Lymphoma, B-Cell, Marginal Zone

Worked with same sponsors:

International Extranodal Lymphoma Study Group (IELSG)
Similarity Score30%

Joan Bargay, MD

Son Llátzer Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Lymphoma, B-Cell, Marginal Zone
Similarity Score30%

Emanuele Zucca, MD

International Extranodal Lymphoma Study Group/Oncology Institute of Southern Switzerland. Bellinzona

Moderately Similar
1 trials

Shared therapeutic areas:

Lymphoma, B-Cell, Marginal Zone

Worked with same sponsors:

International Extranodal Lymphoma Study Group (IELSG)
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT00210392Phase 2StudyChair

VELCADE in MALT Lymphoma Pretreated With More Than One Prior Systemic Therapy

Lymphoma, Mucosa-Associated Lymphoid Tissue
Terminated

All 1 trials loaded